Renal denervation modulates angiotensin receptor expression in the renal cortex of rabbits with chronic heart failure

被引:65
作者
Clayton, Sarah C. [1 ]
Haack, Karla K. V. [1 ]
Zucker, Irving H. [1 ]
机构
[1] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE 68198 USA
关键词
cardiorenal syndrome; norepinephrine; renal sympathetic nerve activity; angiotensin II; II TYPE-1; SYMPATHETIC ACTIVITY; OXIDANT STRESS; NEURAL-CONTROL; SYSTEM; KIDNEY; LOSARTAN; NERVES; NOREPINEPHRINE; HEMODYNAMICS;
D O I
10.1152/ajprenal.00088.2010
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Clayton SC, Haack KK, Zucker IH. Renal denervation modulates angiotensin receptor expression in the renal cortex of rabbits with chronic heart failure. Am J Physiol Renal Physiol 300: F31-F39, 2011. First published October 20, 2010; doi:10.1152/ajprenal.00088.2010.-Excessive sympathetic drive is a hallmark of chronic heart failure (HF). Disease progression can be correlated with plasma norepinephrine concentration. Renal function is also correlated with disease progression and prognosis. Because both the renal nerves and renin-angiotensin II system are activated in chronic HF we hypothesized that excessive renal sympathetic nerve activity decreases renal blood flow in HF and is associated with changes in angiotensin II type 1 receptor (AT1R) and angiotensin II type 2 receptor (AT2R) expression. The present study was carried out in conscious, chronically instrumented rabbits with pacing-induced HF. We found that rabbits with HF showed a decrease in mean renal blood flow (19.8 +/- 1.6 in HF vs. 32.0 +/- 2.5 ml/min from prepace levels; P < 0.05) and an increase in renal vascular resistance (3.26 +/- 0.29 in HF vs. 2.21 +/- 0.13 mmHg.ml(-)1.min in prepace normal rabbits; P < 0.05) while the blood flow and resistance was not changed in HF rabbits with the surgical renal denervation. Renal AT1R expression was increased by similar to 67% and AT2R expression was decreased by similar to 87% in rabbits with HF; however, kidneys from denervated rabbits with HF showed a near normalization in the expression of these receptors. These results suggest renal sympathetic nerve activity elicits a detrimental effect on renal blood flow and may be associated with alterations in the expression of angiotensin II receptors.
引用
收藏
页码:F31 / F39
页数:9
相关论文
共 56 条
[41]   Effects of angiotensin II on autonomic components of nasopharyngeal stimulation in male conscious rabbits [J].
Mousa, TM ;
Gao, L ;
Cornish, KG ;
Zucker, IH .
JOURNAL OF APPLIED PHYSIOLOGY, 2005, 98 (05) :1607-1611
[42]   Effects of long-term renal sympathetic denervation on heart failure after myocardial infarction in rats [J].
Nozawa, T ;
Igawa, A ;
Fujii, N ;
Kato, B ;
Yoshida, N ;
Asanoi, H ;
Inoue, F .
HEART AND VESSELS, 2002, 16 (02) :51-56
[43]   Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats [J].
Otsuka, S ;
Sugano, M ;
Makino, N ;
Sawada, S ;
Hata, T ;
Niho, Y .
HYPERTENSION, 1998, 32 (03) :467-472
[44]   Management of cardiorenal syndrome in heart failure [J].
Patel J. ;
Heywood J.T. .
Current Cardiology Reports, 2006, 8 (3) :211-216
[45]   Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure [J].
Petersson, M ;
Friberg, P ;
Eisenhofer, G ;
Lambert, G ;
Rundqvist, B .
EUROPEAN HEART JOURNAL, 2005, 26 (09) :906-913
[46]   Pathogenesis of hypertension in renal failure: Role of the sympathetic nervous system and renal afferents [J].
Phillips, JK .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2005, 32 (5-6) :415-418
[47]   LACK OF ALPHA-1-ADRENERGIC RECEPTOR-MEDIATED DOWN-REGULATION OF ANGIOTENSIN-II RECEPTORS IN NEURONAL CULTURES FROM SPONTANEOUSLY HYPERTENSIVE RAT-BRAIN [J].
RAIZADA, MK ;
SUMNERS, C .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1989, 91 (1-2) :111-115
[48]   ANG II type 2 receptors and neural control of intrarenal blood flow [J].
Rajapakse, Niwanthi W. ;
Eppel, Gabriela A. ;
Widdop, Robert E. ;
Evans, Roger G. .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2006, 291 (06) :R1669-R1676
[49]   Endothelin antagonism with bosentan: a review of potential applications [J].
Roux, S ;
Breu, V ;
Ertel, SI ;
Clozel, M .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (04) :364-376
[50]   The clinical challenge of cardiorenal syndrome [J].
Shlipak, MG ;
Massie, BM .
CIRCULATION, 2004, 110 (12) :1514-1517